U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's drug ...
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...
Banks are expecting increased M&A activity across the financial sector, but are concerned about acquisition by credit unions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback